UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 614

Sortiert nach

Oncolytic Viruses and Immune Checkpoint Inhibitors: The “Hot” New Power Couple

Cancers, 2023-08, Vol.15 (16), p.4178

2023

Volltextzugriff (PDF)

Designer Oncolytic Adenovirus: Coming of Age

Cancers, 2018-06, Vol.10 (6), p.201

2018

Volltextzugriff (PDF)

Diversity within the adenovirus fiber knob hypervariable loops influences primary receptor interactions

Nature communications, 2019-02, Vol.10 (1), p.741-741, Article 741

2019

Volltextzugriff (PDF)

Engineering Cancer Selective Virotherapies: Are the Pieces of the Puzzle Falling into Place?

Human gene therapy, 2022-11, Vol.33 (21-22), p.1109

2022

Volltextzugriff (PDF)

The Immune System—A Double-Edged Sword for Adenovirus-Based Therapies

Viruses, 2024-06, Vol.16 (6), p.973

2024

Volltextzugriff (PDF)

Oncolytic Adenovirus: Strategies and Insights for Vector Design and Immuno-Oncolytic Applications

Viruses, 2015-11, Vol.7 (11), p.6009-6042

2015

Volltextzugriff (PDF)

Hitting the Target but Missing the Point: Recent Progress towards Adenovirus-Based Precision Virotherapies

Cancers, 2020-11, Vol.12 (11), p.3327

2020

Volltextzugriff (PDF)

Engineering Adenoviral Vectors with Improved GBM Selectivity

Viruses, 2023-04, Vol.15 (5), p.1086

2023

Volltextzugriff (PDF)

The Revolving Door of Adenovirus Cell Entry: Not All Pathways Are Equal

Pharmaceutics, 2021-09, Vol.13 (10), p.1585

2021

Volltextzugriff (PDF)

Identification of coagulation factor (F)X binding sites on the adenovirus serotype 5 hexon: effect of mutagenesis on FX interactions and gene transfer

Blood, 2009-07, Vol.114 (5), p.965-971

2009

Volltextzugriff (PDF)

The Feasibility of Pressurised Intraperitoneal Aerosolised Virotherapy (PIPAV) to Administer Oncolytic Adenoviruses

Pharmaceutics, 2021-11, Vol.13 (12), p.2043

2021

Volltextzugriff (PDF)

Multiple vitamin K-dependent coagulation zymogens promote adenovirus-mediated gene delivery to hepatocytes

Blood, 2006-10, Vol.108 (8), p.2554-2561

2006

Volltextzugriff (PDF)

Efficient Intravenous Tumor Targeting Using the αvβ6 Integrin-Selective Precision Virotherapy Ad5NULL-A20

Viruses, 2021-05, Vol.13 (5), p.864

2021

Volltextzugriff (PDF)

Capture and inactivation of viral particles from bioaerosols by electrostatic precipitation

iScience, 2023-09, Vol.26 (9), p.107567-107567, Article 107567

2023

Volltextzugriff (PDF)

Biodistribution and retargeting of FX-binding ablated adenovirus serotype 5 vectors

Blood, 2010-10, Vol.116 (15), p.2656-2664

2010

Volltextzugriff (PDF)

Identification of cross reactive T cell responses in adenovirus based COVID 19 vaccines

npj vaccines, 2024-06, Vol.9 (1), p.99-12, Article 99

2024

Volltextzugriff (PDF)

In Vitro and In Vivo Evaluation of Human Adenovirus Type 49 as a Vector for Therapeutic Applications

Viruses, 2021-07, Vol.13 (8), p.1483

2021

Volltextzugriff (PDF)

Requirements for receptor engagement during infection by adenovirus complexed with blood coagulation factor X

PLoS pathogens, 2010-10, Vol.6 (10), p.e1001142-e1001142

2010

Volltextzugriff (PDF)

Tropism-modification strategies for targeted gene delivery using adenoviral vectors

Viruses, 2010-10, Vol.2 (10), p.2290-2355

2010

Volltextzugriff (PDF)

A Cluster of Basic Amino Acids in the Factor X Serine Protease Mediates Surface Attachment of Adenovirus/FX Complexes

Journal of Virology, 2011-10, Vol.85 (20), p.10914-10919

2011

Volltextzugriff (PDF)

Genome-wide CRISPR-Cas9 screening reveals ubiquitous T cell cancer targeting via the monomorphic MHC class I-related protein MR1

Nature immunology, 2020-02, Vol.21 (2), p.178

2020

Volltextzugriff (PDF)

Effect of Neutralizing Sera on Factor X-Mediated Adenovirus Serotype 5 Gene Transfer

Journal of Virology, 2009-01, Vol.83 (1), p.479-483

2009

Volltextzugriff (PDF)

Development of a low-seroprevalence, αvβ6 integrin-selective virotherapy based on human adenovirus type 10

Molecular therapy. Oncolytics, 2022-06, Vol.25, p.43-56

2022

Volltextzugriff (PDF)

Targeting of Adenovirus Serotype 5 (Ad5) and 5/47 Pseudotyped Vectors In Vivo: Fundamental Involvement of Coagulation Factors and Redundancy of CAR Binding by Ad5

Journal of Virology, 2007-09, Vol.81 (17), p.9568-9571

2007

Volltextzugriff (PDF)

The aetiopathogenesis of vaccine-induced immune thrombotic thrombocytopenia

Clinical medicine (London, England), 2022-03, Vol.22 (2), p.140-144

2022

Volltextzugriff (PDF)

1 – 25 von 614

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(530)
Mit Volltextzugriff
(528)

Publikationsform

2 weitere anzeigen...

Weniger anzeigen...

Sprache

Englisch
(613)
Japanisch
(71)
Spanisch
(1)

Erscheinungsjahr

n.n

Thema

Science & Technology
(420)
Life Sciences & Biomedicine
(353)
Humans
(309)
Female
(179)
Male
(164)
Biological And Medical Sciences
(115)
Animals
(95)
Medical Sciences
(89)
Adult
(85)
Middle Aged
(78)
Aged
(67)
Physical Sciences
(54)
Child
(46)
Oncology
(45)
Adolescent
(40)
Mice
(39)
Risk Factors
(39)
Tumors
(37)
Genetics & Heredity
(35)
Fundamental And Applied Biological Sciences. Psychology
(34)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(3)

Menü

Weitere Dienste

Einstellungen

Oncolytic Viruses and Immune Checkpoint Inhibitors: The “Hot” New Power Couple

Designer Oncolytic Adenovirus: Coming of Age

Diversity within the adenovirus fiber knob hypervariable loops influences primary receptor interactions

Engineering Cancer Selective Virotherapies: Are the Pieces of the Puzzle Falling into Place?

The Immune System—A Double-Edged Sword for Adenovirus-Based Therapies

Oncolytic Adenovirus: Strategies and Insights for Vector Design and Immuno-Oncolytic Applications

Hitting the Target but Missing the Point: Recent Progress towards Adenovirus-Based Precision Virotherapies

Engineering Adenoviral Vectors with Improved GBM Selectivity

The Revolving Door of Adenovirus Cell Entry: Not All Pathways Are Equal

Identification of coagulation factor (F)X binding sites on the adenovirus serotype 5 hexon: effect of mutagenesis on FX interactions and gene transfer

The Feasibility of Pressurised Intraperitoneal Aerosolised Virotherapy (PIPAV) to Administer Oncolytic Adenoviruses

Multiple vitamin K-dependent coagulation zymogens promote adenovirus-mediated gene delivery to hepatocytes

Efficient Intravenous Tumor Targeting Using the αvβ6 Integrin-Selective Precision Virotherapy Ad5NULL-A20

Capture and inactivation of viral particles from bioaerosols by electrostatic precipitation

Biodistribution and retargeting of FX-binding ablated adenovirus serotype 5 vectors

Identification of cross reactive T cell responses in adenovirus based COVID 19 vaccines

In Vitro and In Vivo Evaluation of Human Adenovirus Type 49 as a Vector for Therapeutic Applications

Requirements for receptor engagement during infection by adenovirus complexed with blood coagulation factor X

Tropism-modification strategies for targeted gene delivery using adenoviral vectors

A Cluster of Basic Amino Acids in the Factor X Serine Protease Mediates Surface Attachment of Adenovirus/FX Complexes

Genome-wide CRISPR-Cas9 screening reveals ubiquitous T cell cancer targeting via the monomorphic MHC class I-related protein MR1

Effect of Neutralizing Sera on Factor X-Mediated Adenovirus Serotype 5 Gene Transfer

Development of a low-seroprevalence, αvβ6 integrin-selective virotherapy based on human adenovirus type 10

Targeting of Adenovirus Serotype 5 (Ad5) and 5/47 Pseudotyped Vectors In Vivo: Fundamental Involvement of Coagulation Factors and Redundancy of CAR Binding by Ad5

The aetiopathogenesis of vaccine-induced immune thrombotic thrombocytopenia

Suchergebnisse filtern